Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects
Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD)...
Saved in:
| Published in | Clinical obesity Vol. 5; no. 1; pp. 42 - 47 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Blackwell Publishing Ltd
01.02.2015
Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1758-8103 1758-8111 |
| DOI | 10.1111/cob.12079 |
Cover
| Abstract | Summary
Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C‐reactive protein. Forty obese individuals (body mass index [BMI] > 35 kg m−2) and 18 healthy (BMI < 25 kg m−2) volunteers participated in this case–control study. Binding activity of serum IgA and IgG to the cell wall mannan of S. cerevisiae was measured by enzyme‐linked immunosorbent assay. More than one‐third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P = 0.01), BMI (P = 0.02) and waist circumference (P = 0.02), but not with C‐reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S. cerevisiae or a related antigen may play a role in the matrix of this complex condition. |
|---|---|
| AbstractList | Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C-reactive protein. Forty obese individuals (body mass index [BMI]>35kgm super(-2)) and 18 healthy (BMI<25kgm super(-2)) volunteers participated in this case-control study. Binding activity of serum IgA and IgG to the cell wall mannan of S.cerevisiae was measured by enzyme-linked immunosorbent assay. More than one-third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P=0.01), BMI (P=0.02) and waist circumference (P=0.02), but not with C-reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S.cerevisiae or a related antigen may play a role in the matrix of this complex condition. Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C-reactive protein. Forty obese individuals (body mass index [BMI]>35kgm-2) and 18 healthy (BMI<25kgm-2) volunteers participated in this case-control study. Binding activity of serum IgA and IgG to the cell wall mannan of S.cerevisiae was measured by enzyme-linked immunosorbent assay. More than one-third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P=0.01), BMI (P=0.02) and waist circumference (P=0.02), but not with C-reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S.cerevisiae or a related antigen may play a role in the matrix of this complex condition. Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C-reactive protein. Forty obese individuals (body mass index [BMI] > 35 kg m(-2) ) and 18 healthy (BMI < 25 kg m(-2) ) volunteers participated in this case-control study. Binding activity of serum IgA and IgG to the cell wall mannan of S. cerevisiae was measured by enzyme-linked immunosorbent assay. More than one-third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P = 0.01), BMI (P = 0.02) and waist circumference (P = 0.02), but not with C-reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S. cerevisiae or a related antigen may play a role in the matrix of this complex condition. Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C‐reactive protein. Forty obese individuals (body mass index [BMI] > 35 kg m−2) and 18 healthy (BMI < 25 kg m−2) volunteers participated in this case–control study. Binding activity of serum IgA and IgG to the cell wall mannan of S. cerevisiae was measured by enzyme‐linked immunosorbent assay. More than one‐third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P = 0.01), BMI (P = 0.02) and waist circumference (P = 0.02), but not with C‐reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S. cerevisiae or a related antigen may play a role in the matrix of this complex condition. |
| Author | Martins, C. Kulseng, B. Salamati, S. |
| Author_xml | – sequence: 1 givenname: S. surname: Salamati fullname: Salamati, S. email: saideh.salamati@stolav.no organization: Center for Obesity, Department of Surgery, St. Olav Hospital - Trondheim University Hospital, Trondheim, Norway – sequence: 2 givenname: C. surname: Martins fullname: Martins, C. organization: Center for Obesity, Department of Surgery, St. Olav Hospital - Trondheim University Hospital, Trondheim, Norway – sequence: 3 givenname: B. surname: Kulseng fullname: Kulseng, B. organization: Center for Obesity, Department of Surgery, St. Olav Hospital - Trondheim University Hospital, Trondheim, Norway |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25611585$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU1v1DAQhi1URD_ogT-ALHGgPaS1N_5IjnRVCtKqXYkiJC7WxJm03iZ2sRPK_nsM2-6hEsxI9mj8vCNr3n2y44NHQt5wdsJznNrQnPAZ0_ULsse1rIoqd3e2NSt3yWFKK5ZDzVQtxSuyO5OKc1nJPXJ9BncY3ye6RkgjPfoC1t5CDMPaYqIWI_50yQEeU_Cju0FPnaehwYS50VIf4gA9fUB3czvSNDUrtGN6TV520Cc8fLwPyNeP59fzT8Xi6uLz_MOisFKJuqg7xrSw-Wy1bGRbaegEIDTScga65sqq1gqugTeyUl1O2wnWAMj8xNvygBxt5t7H8GPCNJrBJYt9Dx7DlAxXiolZXkGZ0XfP0FWYos-_y5TQJROK15l6-0hNzYCtuY9ugLg2T_vKwPEGsDGkFLHbIpyZP3aYbIf5a0dmT5-x1o0wuuDHCK7_n-LB9bj-92gzvzp7UhQbhUsj_toqIN4ZpUstzbfLC7NUi_nyO1uay_I3LKuoxQ |
| CitedBy_id | crossref_primary_10_1016_j_autrev_2023_103486 crossref_primary_10_1016_j_soard_2020_10_021 crossref_primary_10_20935_AcadMed7468 crossref_primary_10_1080_17446651_2020_1719068 crossref_primary_10_1186_s40168_017_0319_x crossref_primary_10_1016_j_ijfoodmicro_2016_08_011 crossref_primary_10_3390_foods11182768 crossref_primary_10_1016_j_bj_2023_100625 crossref_primary_10_3390_foods7040061 crossref_primary_10_1186_s40608_017_0164_2 crossref_primary_10_1016_j_clicom_2024_02_001 crossref_primary_10_1080_21505594_2018_1496779 crossref_primary_10_3390_foods8020070 crossref_primary_10_3390_foods9010089 crossref_primary_10_1016_j_lwt_2020_109918 |
| Cites_doi | 10.1023/A:1019926121972 10.1177/0961203309105131 10.1007/s10620-008-0322-y 10.1136/bmj.297.6656.1105 10.1136/gut.31.5.536 10.1371/journal.pone.0034233 10.1016/j.livsci.2007.01.134 10.1038/cmi.2009.47 10.1016/0195-6663(89)90025-1 10.1371/journal.pone.0012957 10.1155/2012/879151 10.1136/ard.62.5.455 10.1016/S0021-9258(18)72984-0 10.1016/j.nutres.2009.03.002 10.1046/j.1365-2249.2003.02166.x 10.1093/ps/84.4.634 10.3168/jds.S0022-0302(98)75697-8 10.1097/00054725-200403000-00006 10.1016/j.femsim.2004.03.006 10.1172/JCI58109 10.1046/j.1365-2672.2000.01128.x 10.1038/ismej.2007.23 10.3168/jds.S0022-0302(02)74277-X 10.1093/ps/85.3.476 10.54846/jshap/408 10.2323/jgam.51.83 10.1152/ajpgi.00024.2006 10.3168/jds.S0022-0302(93)77608-0 10.15232/S1080-7446(15)31633-8 10.2527/1991.6973016x 10.1007/s10620-010-1541-6 10.1371/journal.pone.0066019 10.3390/ijms10083531 10.1159/000201121 10.1097/00042737-200312000-00005 |
| ContentType | Journal Article |
| Copyright | 2014 World Obesity 2014 World Obesity. Clinical Obesity © 2015 World Obesity |
| Copyright_xml | – notice: 2014 World Obesity – notice: 2014 World Obesity. – notice: Clinical Obesity © 2015 World Obesity |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TS K9. M7N |
| DOI | 10.1111/cob.12079 |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Physical Education Index ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Physical Education Index Algology Mycology and Protozoology Abstracts (Microbiology C) |
| DatabaseTitleList | Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Health & Medical Complete (Alumni) MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1758-8111 |
| EndPage | 47 |
| ExternalDocumentID | 3564570571 25611585 10_1111_cob_12079 COB12079 ark_67375_WNG_P6LCPZ0P_N |
| Genre | article Research Support, Non-U.S. Gov't Journal Article Comparative Study |
| GrantInformation_xml | – fundername: Regional Centre for Obesity, St. Olav University Hospital (RSSO), Trondheim, Norway |
| GroupedDBID | 05W 0R~ 1OC 31~ 33P 4.4 50Y 53G 8-0 8-1 AAESR AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AASGY AAXRX AAYCA AAZKR ABCUV ABDBF ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEUYR AEYWJ AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BHBCM BMXJE BRXPI BSCLL D-A DCZOG DRFUL DRMAN DRSTM EBS EJD FEDTE FUBAC G-S GODZA HGLYW HVGLF HZ~ KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LYRES MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY. MY~ O66 O9- OIG P2W PQQKQ ROL RX1 SUPJJ WBKPD WHWMO WIH WIJ WIK WOHZO WVDHM WXSBR ZZTAW A00 AAHHS ACCFJ ADZOD AEEZP AEQDE AFPWT AIWBW AJBDE P4E WYJ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TS K9. M7N |
| ID | FETCH-LOGICAL-c5649-9f0074cf00d75b5d87af4aeab5c10a7916c6dc417a1b586f6f6cf40baa516c1d3 |
| ISSN | 1758-8103 |
| IngestDate | Fri Sep 05 09:22:05 EDT 2025 Tue Oct 07 06:07:20 EDT 2025 Thu Jan 02 22:16:27 EST 2025 Wed Oct 01 06:04:34 EDT 2025 Thu Apr 24 23:04:18 EDT 2025 Wed Jan 22 16:28:48 EST 2025 Tue Sep 09 05:29:38 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | fungi Saccharomyces cerevisiae antibodies to cell wall mannan of baker's yeast (ASCA) obesity |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2014 World Obesity. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c5649-9f0074cf00d75b5d87af4aeab5c10a7916c6dc417a1b586f6f6cf40baa516c1d3 |
| Notes | ark:/67375/WNG-P6LCPZ0P-N Regional Centre for Obesity, St. Olav University Hospital (RSSO), Trondheim, Norway ArticleID:COB12079 istex:C6AAB7AAF234289915BDFB0B049A770114F2EBAF ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 25611585 |
| PQID | 1647304619 |
| PQPubID | 946374 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1660421033 proquest_journals_1647304619 pubmed_primary_25611585 crossref_primary_10_1111_cob_12079 crossref_citationtrail_10_1111_cob_12079 wiley_primary_10_1111_cob_12079_COB12079 istex_primary_ark_67375_WNG_P6LCPZ0P_N |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-02 February 2015 2015-02-00 2015-Feb 20150201 |
| PublicationDateYYYYMMDD | 2015-02-01 |
| PublicationDate_xml | – month: 02 year: 2015 text: 2015-02 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Clinical obesity |
| PublicationTitleAlternate | Clinical Obesity |
| PublicationYear | 2015 |
| Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
| References | Miles RD, Butcher GD, Henry PR, Littell RC. Effect of antibiotic growth promoters on broiler performance, intestinal growth parameters, and quantitative morphology. Poult Sci 2006; 85: 476-485. Newbold C, Olvera-Ramirez A. The use of yeast-based probiotics to meet new challenges in ruminant production. J Anim Sci 2006; 84: 425. Piva G, Belladonna S, Fusconi G, Sicbaldi F. Effects of yeast on dairy-cow performance, ruminal fermentation, blood components, and milk manufacturing properties. J Dairy Sci 1993; 76: 2717-2722. Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum IgA against Saccharomyces cerevisiae mannan in patients with rheumatoid arthritis. Cell Mol Immunol 2009; 6: 361-366. Turner JL, Dritz SS, Minton JE. Review: alternatives to conventional antimicrobials in swine diets. Prof Anim Sci 2001; 17: 217-226. Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus. Lupus 2009; 18: 1087-1090. Buts JP. Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Dig Dis Sci 2009; 54: 15-18. Hoffmann C, Dollive S, Grunberg S et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE 2013; 8: e66019. Pang X, Hua X, Yang Q et al. Inter-species transplantation of gut microbiota from human to pigs. ISME J 2007; 1: 156-162. Mendall MA, Gunasekera AV, John BJ, Kumar D. Is obesity a risk factor for Crohn's disease? Dig Dis Sci 2011; 56: 837-844. Muratori P, Muratori L, Guidi M et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003; 132: 473-476. Konrad A, Rutten C, Flogerzi B et al. Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease. Inflamm Bowel Dis 2004; 10: 97-105. Harrer M, Reinisch W, Dejaco C et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol 2003; 15: 1281-1285. von Dongern E. Beitrage zur immunitatslehre. Münchener Med Wochenschr 1900; 47: 677-680. Kabir SML. The role of probiotics in the poultry industry. Int J Mol Sci 2009; 10: 3531-3546. Miller-Webster T, Hoover WH, Holt M, Nocek JE. Influence of yeast culture on ruminal microbial metabolism in continuous culture. J Dairy Sci 2002; 85: 2009-2014. Damoiseaux JG, Bouten B, Linders AM et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002; 22: 281-288. Main J, McKenzie H, Yeaman GR et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988; 297: 1105-1106. Larsson B, Seidell J, Svardsudd K et al. Obesity, adipose tissue distribution and health in men - the study of men born in 1913. Appetite 1913; 13: 37-44. Pillemer L, Ecker E. Anticomplementary factor in fresh yeast. J Biol Chem 1941; 137: 139-142. Kohl A, Gogebakan O, Mohlig M et al. Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-β-glycan consumption in overweight humans. Nutr Res 2009; 29: 248-254. Kogan G, Kocher A. Role of yeast cell wall polysaccharides in pig nutrition and health protection. Livest Sci 2007; 109: 161-165. Schulze J, Sonnenborn U. Yeasts in the gut: from commensals to infectious agents. Deutsch Arztebl Int 2009; 106: 837-842. Young CA, Sonnenberg A, Burns EA. Lymphocyte proliferation response to baker's yeast in Crohn's disease. Digestion 1994; 55: 40-43. Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies - a novel serologic marker for Behçet's disease. Clin Exp Rheumatol 2002; 20(Suppl. 26): 21-24. Williams PEV, Tait CAG, Innes GM, Newbold CJ. Effects of the inclusion of yeast culture (Saccharomyces cerevisiae plus growth-medium) in the diet of dairy-cows on milk-yield and forage degradation and fermentation patterns in the rumen of steers. J Anim Sci 1991; 69: 3016-3026. Lam YY, Ha CW, Campbell CR et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS ONE 2012; 7: e34233. Brun P, Castagliuolo I, Di Leo V et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518-G525. Saegusa S, Totsuka M, Kaminogawa S, Hosoi T. Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol Med Microbiol 2004; 41: 227-235. Hoffman IE, Demetter P, Peeters M et al. Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 2003; 62: 455-459. McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (bakers and brewers-yeast) and Candida albicans in Crohn's disease. Gut 1990; 31: 536-538. Miguel JC, Rodriguez-Zas SL, Pettigrew JE. Efficacy of a mannan oligosaccharide (Bio-Mos((R))) for improving nursery pig performance. J Swine Health Prod 2004; 12: 296-307. Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: history and mode of action. Poult Sci 2005; 84: 634-643. Wohlt JE, Corcione TT, Zajac PK. Effect of yeast on feed intake and performance of cows fed diets based on corn silage during early lactation. J Dairy Sci 1998; 81: 1345-1352. Martins FS, Nardi RMD, Arantes RME et al. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 2005; 51: 83-92. Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012; 2012: 1-14. Papp M, Norman GL, Vitalis Z et al. Presence of anti-microbial antibodies in liver cirrhosis - a tell-tale sign of compromised immunity? PLoS ONE 2010; 5: e12957. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011; 121: 2126-2132. Rodrigues ACP, Cara DC, Fretez SHGG et al. Saccharomyces boulardii stimulates slgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 2000; 89: 404-414. 1990; 31 2004; 41 2012; 2012 1941; 137 2000; 89 2005; 84 2003; 15 1998; 81 2011; 56 1913; 13 2013; 8 2007; 109 2003; 132 2009; 29 2004; 10 2006; 85 1991; 69 2009; 10 2009; 54 2006; 84 2002; 85 2002; 20 2007; 292 1993; 76 2004; 12 2002; 22 2005; 51 1994; 55 1988; 297 2009; 6 1900; 47 2001; 17 2007; 1 2012; 7 2010; 5 2003; 62 2011; 121 2009; 18 2009; 106 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 Miguel JC (e_1_2_10_6_1) 2004; 12 Pillemer L (e_1_2_10_33_1) 1941; 137 Krause I (e_1_2_10_16_1) 2002; 20 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_39_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_10_1 e_1_2_10_11_1 e_1_2_10_31_1 e_1_2_10_30_1 Newbold C (e_1_2_10_9_1) 2006; 84 Dongern E (e_1_2_10_32_1) 1900; 47 Schulze J (e_1_2_10_40_1) 2009; 106 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_28_1 e_1_2_10_25_1 e_1_2_10_26_1 |
| References_xml | – reference: Mendall MA, Gunasekera AV, John BJ, Kumar D. Is obesity a risk factor for Crohn's disease? Dig Dis Sci 2011; 56: 837-844. – reference: Brun P, Castagliuolo I, Di Leo V et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518-G525. – reference: Schulze J, Sonnenborn U. Yeasts in the gut: from commensals to infectious agents. Deutsch Arztebl Int 2009; 106: 837-842. – reference: Miles RD, Butcher GD, Henry PR, Littell RC. Effect of antibiotic growth promoters on broiler performance, intestinal growth parameters, and quantitative morphology. Poult Sci 2006; 85: 476-485. – reference: Williams PEV, Tait CAG, Innes GM, Newbold CJ. Effects of the inclusion of yeast culture (Saccharomyces cerevisiae plus growth-medium) in the diet of dairy-cows on milk-yield and forage degradation and fermentation patterns in the rumen of steers. J Anim Sci 1991; 69: 3016-3026. – reference: Rodrigues ACP, Cara DC, Fretez SHGG et al. Saccharomyces boulardii stimulates slgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 2000; 89: 404-414. – reference: Pillemer L, Ecker E. Anticomplementary factor in fresh yeast. J Biol Chem 1941; 137: 139-142. – reference: Pang X, Hua X, Yang Q et al. Inter-species transplantation of gut microbiota from human to pigs. ISME J 2007; 1: 156-162. – reference: Kogan G, Kocher A. Role of yeast cell wall polysaccharides in pig nutrition and health protection. Livest Sci 2007; 109: 161-165. – reference: Konrad A, Rutten C, Flogerzi B et al. Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease. Inflamm Bowel Dis 2004; 10: 97-105. – reference: Buts JP. Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Dig Dis Sci 2009; 54: 15-18. – reference: Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012; 2012: 1-14. – reference: Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011; 121: 2126-2132. – reference: Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: history and mode of action. Poult Sci 2005; 84: 634-643. – reference: von Dongern E. Beitrage zur immunitatslehre. Münchener Med Wochenschr 1900; 47: 677-680. – reference: Kabir SML. The role of probiotics in the poultry industry. Int J Mol Sci 2009; 10: 3531-3546. – reference: Muratori P, Muratori L, Guidi M et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003; 132: 473-476. – reference: Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus. Lupus 2009; 18: 1087-1090. – reference: Martins FS, Nardi RMD, Arantes RME et al. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 2005; 51: 83-92. – reference: Damoiseaux JG, Bouten B, Linders AM et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002; 22: 281-288. – reference: Miguel JC, Rodriguez-Zas SL, Pettigrew JE. Efficacy of a mannan oligosaccharide (Bio-Mos((R))) for improving nursery pig performance. J Swine Health Prod 2004; 12: 296-307. – reference: Turner JL, Dritz SS, Minton JE. Review: alternatives to conventional antimicrobials in swine diets. Prof Anim Sci 2001; 17: 217-226. – reference: Hoffmann C, Dollive S, Grunberg S et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE 2013; 8: e66019. – reference: Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum IgA against Saccharomyces cerevisiae mannan in patients with rheumatoid arthritis. Cell Mol Immunol 2009; 6: 361-366. – reference: Saegusa S, Totsuka M, Kaminogawa S, Hosoi T. Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol Med Microbiol 2004; 41: 227-235. – reference: Miller-Webster T, Hoover WH, Holt M, Nocek JE. Influence of yeast culture on ruminal microbial metabolism in continuous culture. J Dairy Sci 2002; 85: 2009-2014. – reference: Kohl A, Gogebakan O, Mohlig M et al. Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-β-glycan consumption in overweight humans. Nutr Res 2009; 29: 248-254. – reference: Larsson B, Seidell J, Svardsudd K et al. Obesity, adipose tissue distribution and health in men - the study of men born in 1913. Appetite 1913; 13: 37-44. – reference: Papp M, Norman GL, Vitalis Z et al. Presence of anti-microbial antibodies in liver cirrhosis - a tell-tale sign of compromised immunity? PLoS ONE 2010; 5: e12957. – reference: Main J, McKenzie H, Yeaman GR et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988; 297: 1105-1106. – reference: Harrer M, Reinisch W, Dejaco C et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol 2003; 15: 1281-1285. – reference: McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (bakers and brewers-yeast) and Candida albicans in Crohn's disease. Gut 1990; 31: 536-538. – reference: Lam YY, Ha CW, Campbell CR et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS ONE 2012; 7: e34233. – reference: Wohlt JE, Corcione TT, Zajac PK. Effect of yeast on feed intake and performance of cows fed diets based on corn silage during early lactation. J Dairy Sci 1998; 81: 1345-1352. – reference: Piva G, Belladonna S, Fusconi G, Sicbaldi F. Effects of yeast on dairy-cow performance, ruminal fermentation, blood components, and milk manufacturing properties. J Dairy Sci 1993; 76: 2717-2722. – reference: Hoffman IE, Demetter P, Peeters M et al. Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 2003; 62: 455-459. – reference: Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies - a novel serologic marker for Behçet's disease. Clin Exp Rheumatol 2002; 20(Suppl. 26): 21-24. – reference: Newbold C, Olvera-Ramirez A. The use of yeast-based probiotics to meet new challenges in ruminant production. J Anim Sci 2006; 84: 425. – reference: Young CA, Sonnenberg A, Burns EA. Lymphocyte proliferation response to baker's yeast in Crohn's disease. Digestion 1994; 55: 40-43. – volume: 1 start-page: 156 year: 2007 end-page: 162 article-title: Inter‐species transplantation of gut microbiota from human to pigs publication-title: ISME J – volume: 13 start-page: 37 year: 1913 end-page: 44 article-title: Obesity, adipose tissue distribution and health in men – the study of men born in 1913 publication-title: Appetite – volume: 2012 start-page: 1 year: 2012 end-page: 14 article-title: Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? publication-title: J Obes – volume: 109 start-page: 161 year: 2007 end-page: 165 article-title: Role of yeast cell wall polysaccharides in pig nutrition and health protection publication-title: Livest Sci – volume: 31 start-page: 536 year: 1990 end-page: 538 article-title: Antibody to selected strains of (bakers and brewers‐yeast) and in Crohn's disease publication-title: Gut – volume: 89 start-page: 404 year: 2000 end-page: 414 article-title: stimulates slgA production and the phagocytic system of gnotobiotic mice publication-title: J Appl Microbiol – volume: 69 start-page: 3016 year: 1991 end-page: 3026 article-title: Effects of the inclusion of yeast culture ( plus growth‐medium) in the diet of dairy‐cows on milk‐yield and forage degradation and fermentation patterns in the rumen of steers publication-title: J Anim Sci – volume: 55 start-page: 40 year: 1994 end-page: 43 article-title: Lymphocyte proliferation response to baker's yeast in Crohn's disease publication-title: Digestion – volume: 47 start-page: 677 year: 1900 end-page: 680 article-title: Beitrage zur immunitatslehre publication-title: Münchener Med Wochenschr – volume: 7 start-page: e34233 year: 2012 article-title: Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet‐induced obese mice publication-title: PLoS ONE – volume: 84 start-page: 634 year: 2005 end-page: 643 article-title: Antibiotic growth promoters in agriculture: history and mode of action publication-title: Poult Sci – volume: 84 start-page: 425 year: 2006 article-title: The use of yeast‐based probiotics to meet new challenges in ruminant production publication-title: J Anim Sci – volume: 29 start-page: 248 year: 2009 end-page: 254 article-title: Increased interleukin‐10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)‐β‐glycan consumption in overweight humans publication-title: Nutr Res – volume: 62 start-page: 455 year: 2003 end-page: 459 article-title: Anti‐ IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy publication-title: Ann Rheum Dis – volume: 121 start-page: 2126 year: 2011 end-page: 2132 article-title: Gut microbiome, obesity, and metabolic dysfunction publication-title: J Clin Invest – volume: 54 start-page: 15 year: 2009 end-page: 18 article-title: Twenty‐five years of research on trophic effects: updates and perspectives publication-title: Dig Dis Sci – volume: 8 start-page: e66019 year: 2013 article-title: Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents publication-title: PLoS ONE – volume: 297 start-page: 1105 year: 1988 end-page: 1106 article-title: Antibody to (bakers’ yeast) in Crohn's disease publication-title: BMJ – volume: 41 start-page: 227 year: 2004 end-page: 235 article-title: and induce interleukin‐8 production from intestinal epithelial‐like Caco‐2 cells in the presence of butyric acid publication-title: FEMS Immunol Med Microbiol – volume: 106 start-page: 837 year: 2009 end-page: 842 article-title: Yeasts in the gut: from commensals to infectious agents publication-title: Deutsch Arztebl Int – volume: 51 start-page: 83 year: 2005 end-page: 92 article-title: Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice publication-title: J Gen Appl Microbiol – volume: 137 start-page: 139 year: 1941 end-page: 142 article-title: Anticomplementary factor in fresh yeast publication-title: J Biol Chem – volume: 6 start-page: 361 year: 2009 end-page: 366 article-title: Elevated levels of serum IgA against mannan in patients with rheumatoid arthritis publication-title: Cell Mol Immunol – volume: 5 start-page: e12957 year: 2010 article-title: Presence of anti‐microbial antibodies in liver cirrhosis – a tell‐tale sign of compromised immunity? publication-title: PLoS ONE – volume: 132 start-page: 473 year: 2003 end-page: 476 article-title: Anti‐ antibodies (ASCA) and autoimmune liver diseases publication-title: Clin Exp Immunol – volume: 76 start-page: 2717 year: 1993 end-page: 2722 article-title: Effects of yeast on dairy‐cow performance, ruminal fermentation, blood components, and milk manufacturing properties publication-title: J Dairy Sci – volume: 56 start-page: 837 year: 2011 end-page: 844 article-title: Is obesity a risk factor for Crohn's disease? publication-title: Dig Dis Sci – volume: 292 start-page: G518 year: 2007 end-page: G525 article-title: Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 22 start-page: 281 year: 2002 end-page: 288 article-title: Diagnostic value of anti‐ and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease publication-title: J Clin Immunol – volume: 18 start-page: 1087 year: 2009 end-page: 1090 article-title: Elevated levels of serum antibodies against mannan in patients with systemic lupus erythematosus publication-title: Lupus – volume: 81 start-page: 1345 year: 1998 end-page: 1352 article-title: Effect of yeast on feed intake and performance of cows fed diets based on corn silage during early lactation publication-title: J Dairy Sci – volume: 10 start-page: 3531 year: 2009 end-page: 3546 article-title: The role of probiotics in the poultry industry publication-title: Int J Mol Sci – volume: 15 start-page: 1281 year: 2003 end-page: 1285 article-title: Do high serum levels of anti‐ antibodies result from a leakiness of the gut barrier in Crohn's disease? publication-title: Eur J Gastroenterol Hepatol – volume: 12 start-page: 296 year: 2004 end-page: 307 article-title: Efficacy of a mannan oligosaccharide (Bio‐Mos((R))) for improving nursery pig performance publication-title: J Swine Health Prod – volume: 85 start-page: 476 year: 2006 end-page: 485 article-title: Effect of antibiotic growth promoters on broiler performance, intestinal growth parameters, and quantitative morphology publication-title: Poult Sci – volume: 85 start-page: 2009 year: 2002 end-page: 2014 article-title: Influence of yeast culture on ruminal microbial metabolism in continuous culture publication-title: J Dairy Sci – volume: 17 start-page: 217 year: 2001 end-page: 226 article-title: Review: alternatives to conventional antimicrobials in swine diets publication-title: Prof Anim Sci – volume: 20 start-page: 21 issue: Suppl. 26 year: 2002 end-page: 24 article-title: Anti‐ antibodies – a novel serologic marker for Behçet's disease publication-title: Clin Exp Rheumatol – volume: 10 start-page: 97 year: 2004 end-page: 105 article-title: Immune sensitization to yeast antigens in ASCA‐positive patients with Crohn's disease publication-title: Inflamm Bowel Dis – ident: e_1_2_10_25_1 doi: 10.1023/A:1019926121972 – ident: e_1_2_10_23_1 doi: 10.1177/0961203309105131 – ident: e_1_2_10_36_1 doi: 10.1007/s10620-008-0322-y – ident: e_1_2_10_15_1 doi: 10.1136/bmj.297.6656.1105 – ident: e_1_2_10_20_1 doi: 10.1136/gut.31.5.536 – ident: e_1_2_10_31_1 doi: 10.1371/journal.pone.0034233 – ident: e_1_2_10_7_1 doi: 10.1016/j.livsci.2007.01.134 – ident: e_1_2_10_22_1 doi: 10.1038/cmi.2009.47 – ident: e_1_2_10_30_1 doi: 10.1016/0195-6663(89)90025-1 – ident: e_1_2_10_19_1 doi: 10.1371/journal.pone.0012957 – ident: e_1_2_10_2_1 doi: 10.1155/2012/879151 – ident: e_1_2_10_24_1 doi: 10.1136/ard.62.5.455 – volume: 137 start-page: 139 year: 1941 ident: e_1_2_10_33_1 article-title: Anticomplementary factor in fresh yeast publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)72984-0 – ident: e_1_2_10_34_1 doi: 10.1016/j.nutres.2009.03.002 – volume: 20 start-page: 21 issue: 26 year: 2002 ident: e_1_2_10_16_1 article-title: Anti‐Saccharomyces cerevisiae antibodies – a novel serologic marker for Behçet's disease publication-title: Clin Exp Rheumatol – ident: e_1_2_10_18_1 doi: 10.1046/j.1365-2249.2003.02166.x – ident: e_1_2_10_3_1 doi: 10.1093/ps/84.4.634 – ident: e_1_2_10_11_1 doi: 10.3168/jds.S0022-0302(98)75697-8 – ident: e_1_2_10_17_1 doi: 10.1097/00054725-200403000-00006 – volume: 47 start-page: 677 year: 1900 ident: e_1_2_10_32_1 article-title: Beitrage zur immunitatslehre publication-title: Münchener Med Wochenschr – ident: e_1_2_10_37_1 doi: 10.1016/j.femsim.2004.03.006 – ident: e_1_2_10_21_1 doi: 10.1172/JCI58109 – ident: e_1_2_10_35_1 doi: 10.1046/j.1365-2672.2000.01128.x – ident: e_1_2_10_8_1 doi: 10.1038/ismej.2007.23 – ident: e_1_2_10_14_1 doi: 10.3168/jds.S0022-0302(02)74277-X – ident: e_1_2_10_4_1 doi: 10.1093/ps/85.3.476 – volume: 12 start-page: 296 year: 2004 ident: e_1_2_10_6_1 article-title: Efficacy of a mannan oligosaccharide (Bio‐Mos((R))) for improving nursery pig performance publication-title: J Swine Health Prod doi: 10.54846/jshap/408 – ident: e_1_2_10_39_1 doi: 10.2323/jgam.51.83 – volume: 106 start-page: 837 year: 2009 ident: e_1_2_10_40_1 article-title: Yeasts in the gut: from commensals to infectious agents publication-title: Deutsch Arztebl Int – ident: e_1_2_10_28_1 doi: 10.1152/ajpgi.00024.2006 – ident: e_1_2_10_13_1 doi: 10.3168/jds.S0022-0302(93)77608-0 – ident: e_1_2_10_5_1 doi: 10.15232/S1080-7446(15)31633-8 – volume: 84 start-page: 425 year: 2006 ident: e_1_2_10_9_1 article-title: The use of yeast‐based probiotics to meet new challenges in ruminant production publication-title: J Anim Sci – ident: e_1_2_10_10_1 doi: 10.2527/1991.6973016x – ident: e_1_2_10_29_1 doi: 10.1007/s10620-010-1541-6 – ident: e_1_2_10_38_1 doi: 10.1371/journal.pone.0066019 – ident: e_1_2_10_12_1 doi: 10.3390/ijms10083531 – ident: e_1_2_10_26_1 doi: 10.1159/000201121 – ident: e_1_2_10_27_1 doi: 10.1097/00042737-200312000-00005 |
| SSID | ssj0000626954 |
| Score | 1.9913292 |
| Snippet | Summary
Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the... Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed... Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the... |
| SourceID | proquest pubmed crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 42 |
| SubjectTerms | Adult antibodies to cell wall mannan of baker's yeast (ASCA) Antibodies, Fungal - immunology Body mass index C-Reactive Protein - immunology Case-Control Studies Cell Wall - immunology Crohn Disease - immunology Crohn Disease - microbiology Enzyme-Linked Immunosorbent Assay Female Food Hypersensitivity - immunology fungi Humans Ideal Body Weight - immunology Immunoglobulin A - immunology Immunoglobulin G - immunology Male Obesity Obesity - immunology Phenotype Probiotics Saccharomyces cerevisiae Saccharomyces cerevisiae - immunology Yeast |
| Title | Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects |
| URI | https://api.istex.fr/ark:/67375/WNG-P6LCPZ0P-N/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcob.12079 https://www.ncbi.nlm.nih.gov/pubmed/25611585 https://www.proquest.com/docview/1647304619 https://www.proquest.com/docview/1660421033 |
| Volume | 5 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1758-8111 dateEnd: 20241105 omitProxy: true ssIdentifier: ssj0000626954 issn: 1758-8103 databaseCode: ABDBF dateStart: 20130201 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwELdYKyG-IN4UxmQQgqEoVdzGeXxcCmMCWip106Z9iWzHkSZGgpZWMP56zo-4LeukgSpZkeMkte_n8935fIfQ65AVQ5nGpR-FLPBDEUY-k7H0E16ykohIML1jOp5EB0fhpxN6sjx7ok-XzHlf_N54ruR_qAp1QFd1SvYfKOteChVwDfSFEigM5Y1onDHtExE33qVKwaOkRW_mMaGOUtXfL5WzldB-vM0ZU7Jk6sE4qvCbyspRc9mYvYNKya3n3k9tJfWaBVe2mWZVbB215ydrk0fA2WUYAIoZj4BZf2ndVqEJTOwCV_l5AYuwYSxZf9XWQGjrnuzYI2gXfkICw5Lkap1lmZan0ivQMfzRRNKyK60JtXkNDxc175NBYDLNrMfJ_mv9cl6FrT4Dj-b60S3UHQCzDzqou5e9z_ad8S0ANS7VGfJcj2zUKeXl5T69Jqt01bT7tUkRWddrtGByeA_dtRoF3jPwuI9uyeoBuj22PhMP0bFGydsGa4zgXTzDqwjBS4Tgd9jiA59VWOMDKgps8IENPnCLj0foaP_D4ejAt-k0fEGjMPXTUsmLAsoippwWSczKkEnGqSABi0FPEFEhQhIzwmkSlfATZRhwxijcIsXwMepUdSWfIpxKmsLjBawHoBLwIiFlIpjkrFTh3Qakh3bbgcuFjTWvUp6c51do1EOvXNMfJsDKpkZv9Oi7Fuzim_JIjGl-PPmYT6Mvo-lpMM0nPbTdkie3E7XJVcg8nVgA3vPS3QY2qvbGWCXrhWoTwfIFOBj20BNDVvcx0ApAb0oo9ErT-fr_mY--Zvri2U169RzdWU6ybdSZXyzkCxBx53zHAnYHbU2m4z8oeKOp |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Baker%27s+yeast+%28+S+accharomyces+cerevisiae+%29+antigen+in+obese+and+normal+weight+subjects&rft.jtitle=Clinical+obesity&rft.au=Salamati%2C+S.&rft.au=Martins%2C+C.&rft.au=Kulseng%2C+B.&rft.date=2015-02-01&rft.issn=1758-8103&rft.eissn=1758-8111&rft.volume=5&rft.issue=1&rft.spage=42&rft.epage=47&rft_id=info:doi/10.1111%2Fcob.12079&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_cob_12079 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-8103&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-8103&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-8103&client=summon |